Screener
Amneal Pharmaceuticals, Inc. AMRX Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
FAQ
- What is Amneal Pharmaceuticals, Inc.'s free cash flow margin?
- Amneal Pharmaceuticals, Inc. (AMRX) reported free cash flow margin of 4.1% in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s free cash flow margin changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s free cash flow margin decreased by 58.7% year-over-year, from 9.9% to 4.1%.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s free cash flow margin?
- Over 3 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s free cash flow margin has grown at a -18.0% compound annual growth rate (CAGR), from 16.2% to 8.9%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Amneal Pharmaceuticals, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude